Related Articles

• 2009 Top 10 Innovations
• Arena’s Obesity Drug Trial Shows Patients Lose Moderate Amount of Weight
• Biomedical Industry Becomes Increasingly Vital to State's Economic Stability, Finds California Healthcare Institute and PricewaterhouseCoopers
• Biomedical Industry Jobs Critical to California’s Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
• Biotech Industry Attracts the Most Venture Capital
• California Healthcare Institute Supports Introduction of Biosimilars Legislation
• California Scientists Sound Alarms About National Institutes of Health
• Cancer Major Focus of R&D Efforts in California, but Cures Hard to Come By
• Celebrating Global and Local Biotech Breakthroughs in San Diego
• Celera's Blood Test May Diagnose Lung Cancer
• CHI Announces Dr. Topol as Keynote Speaker
• CHI Blog Interviews Mark Smith, M.D., President and CEO of California HealthCare Foundation, Speaker at the 2009 California Healthcare Policy Forum
• CHI Blog: Executive Spotlight: Melinda Richter, Executive Director, San Jose BioCenter
• CHI in Washington, D.C.: Inform. Innovate. Inspire.
• CHI Joins Coalition in Support of National Pedigree Standard
• CHI Launches Podcast to Help Entrepreneurs Find New Sources of Funding
• CHI Members Called to Help Combat Swine Flu
• CHI Patient Perspectives Podcast Series New Episode: A New Model for Funding Research
• CHI Patient Perspectives Podcast Series New Episode: Finding a Cure: Duchenne
• CHI Patient Perspectives Podcast Series Premieres
• CHI Reporting from 2009 BIO Convention in Atlanta
• CHI to Launch 2010 California Biomedical Industry Report Feb. 2 in Sacramento
• CHI's First-Ever Environmental Summit - March 1 Deadline - Act Fast!
• CIRM Seeks to Protect Exclusivity for Biosimilars
• Commentary: We Need a Science White House
• Congress Works to Resolve Differences in Healthcare Reform Bills
• Congressman Jerry McNerney to Join CHI for Roundtable in Washington, D.C.
• Diabetes Education Event Will Present Revolutionary New Treatments and Research to Battle California's Seventh Leading Killer
• Diabetes: Bay Area companies fighting epidemic
• Drug Libraries May Help Discover New Treatments
• Early Bird Registration Now Available for The Healthcare Policy Forum-Innovation at a Crossroads
• Editorial: Complexity of Biotech Drugs Means Copying Them is Risky(2)
• Executive Spotlight: CardioDX Founder and CEO Speaks About Personalizing Cardiovascular Treatments
• Executive Spotlight: Corventis CEO Speaks with CHI About New Technology to Address Most Expensive Ailment
• Executive Spotlight: Mickey Urdea, Ph.D., Chairman, CEO and Founder of Tethys Bioscience
• Executive Spotlight: Navigenics' CEO Speaks About The Future of Genetic Testing
• Executive Spotlight: Pierre Cassigneul, President and CEO, XDx
• FDA May Support New Testing Method for Drugs
• FDA to Aid Tropical Disease Research
• Genentech Cancer Drug Approved for Kidney Cancer
• Genetic Test Helps Prognosis for Patients with Colon Cancer
• Gen-Probe Says Business is Good
• Gilead’s Drug Trial Shows Half of Patients Successfully Lowered Blood Pressure
• Growth Industry in California
• Life Sciences Industry Applauds Jerry Hill's Appointment to Chair Biotechnology Committee
• Media - California’s Biomedical Industry is ‘Recession Resilient’
• Media: California’s Biomedical Industry is ‘Recession Resilient’
• Nanotechnology New Area of Research for Cancer Therapy
• Navigenics and Scripps to Team Up to Study Patient Behavior
• New Breast Cancer Diagnostic Tests Introduced
• New Deals Energize Biotech Sector
• New HIV Therapy Boosts Immune Systems
• New Pediatric Cancer Research Center Opens in San Diego
• NEW PODCAST: CHI Patient Perspectives Podcast Series: New Approaches to Treatment Needed in Pediatric Cancer
• New report finds stagnant NIH funding shackling young researchers
• New test predicts risk of post-surgery kidney injury
• Non-Hodgkin's cancer patients living longer according to new study
• Non-Profit Foundations Funding Research on “Orphan Diseases”
• Patients Share Their Stories at the 2010 California Biomedical Industry Report Launch Feb. 2 in Sacramento
• PBS to Air Three-Part Series on Rare Disease Diagnosis through Technology
• Pfizer Abandons Plans to Build Biotech Research Center in San Francisco
• PODCAST: Personalized Medicine is Transforming Healthcare
• Protein Detected in Brain Might Shed Light on Alzheimer's
• Proteus Biomedical Prescribes 'Smart Pill'
• Proteus Biomedical: Smart Pills the Wave of the Future
• Redefining Disease May Aid in Better Diagnostics, Therapies
• Report Calls Private Sector Funding 'Critical' to Biomedical Innovation
• Report: Diagnostic Tests Are Crucial to Health Reform
• Reversing California's Downward Trend: OpEd by Carl Hull, Gen-Probe Incorporated
• Roche Offers $43.7 Billion for Rest of Genentech
• Roche Unveils New Cancer Drug Data
• San Diego Biotechs Receive Stem Cell Grants
• Sangamo Upbeat on Drug for Diabetic Nerve Damage
• Sequenom to Expand in Michigan
• Silicon Valley Biomedical Sector is Growing Despite Recession
• Speakers Announced for Environmental Summit
• Sponsorship Deadline March 6 for Celebration of California Biomedical Innovation Event in D.C.
• Stanford Scientists Discover Stem Cell Advance for Stroke Treatment
• Stem Cell Therapy Breakthrough May Have Implications for Major Diseases
• The Future of Personalized Medicine
• The National Cancer Institute Cancer Human Biobank (caHUB) Public Information Meeting
• Three San Diego Companies Battle Obesity
• TSRI Researchers Discover Potential Drug Targets for Sepsis
• Turning Personalized Medicine into Reality
• UCSD Forms New Medical Engineering Institute
• UCSF and Genentech Work Together on Neurodegenerative Diseases
• University of California to Undertake Groundbreaking Breast Cancer Study
• Warning Over Drug Trial's Effects on Testing
• Webcast Now Available: 2010 California Biomedical Industry Report
• Wyeth Shares Rise on Promising Study of Alzheimer's Drug